Error‐prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment

Abstract excerpt

Defects in DNA repair machinery play a critical role in the pathogenesis and progression of human cancer. When they occur, the tumor cells activate error-prone mechanisms which lead to genomic instability and high mutation rate. These defects represent, therefore, a cancer Achilles'heel which could be therapeutically exploited by the use of DNA damage response inhibitors. Moreover, experimental and clinical...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Immunotherapy and Biomarkers
• Share to DNA Repair Mechanisms
• Share to PARP inhibition in cancer therapy